Aberrant miRNA promoter methylation and EMT‐involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications

Breast cancer (BC) is the most prevalent cancer in women worldwide. Although extensive studies are ongoing concerning its intricate molecular mechanisms, development of novel therapies and more accurate diagnostic and prognostic approaches is still a challenge. Epithelial–mesenchymal transition (EMT) enables the invasion of metastatic cancer cells and has recently been highlighted in a Cancer Stem Cell (CSC) model of BC. Epigenetic events as well as miRNA expression are the master regulators of tumorigenesis and add a further layer to the complexity of BC pathogenesis. The miRNAs are related to epigenetic event and additionally affect epigenetic pathways. Recent evidence demonstrates that epigenetic mechanisms such as DNA methylation may control miRNA expression. Because each miRNA may regulate several target genes, dysregulation of miRNA caused by aberrant DNA methylation patterns of the locus may influence important downstream pathways. Furthermore, some miRNAs is believed to regulate important DNA methylator factors. Any disruption or modification of this intricate network can contribute to the disease process; thus, it is essential to understand these changes. Advancements in new sequencing technologies to detect DNA methylation patterns has provided the opportunity to determine differentially methylated regions (DMRs) of the miRNA locus and their effect on expression profiles to improve BC diagnosis and treatment. The current review examines the interplay of DNA methylation mechanisms and miRNA function in invasive tumorigenesis, specifically EMT and CSC of BC, to highlight its potential for advancements on BC etiology, diagnosis, and therapy.

[1]  Haikuo Zhang,et al.  TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine , 2010, Cell Research.

[2]  Chun-Wen Cheng,et al.  MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer , 2012, Breast Cancer Research and Treatment.

[3]  T. Spector,et al.  DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker , 2012, Carcinogenesis.

[4]  T. Zhu,et al.  MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression , 2012, PloS one.

[5]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[6]  K. Gogineni,et al.  A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer , 2016, Breast cancer : basic and clinical research.

[7]  F. Yu,et al.  MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells* , 2011, The Journal of Biological Chemistry.

[8]  Kornelia Polyak,et al.  Heterogeneity in breast cancer. , 2011, The Journal of clinical investigation.

[9]  C. Pikaard,et al.  The RNAs of RNA-directed DNA methylation. , 2017, Biochimica et biophysica acta. Gene regulatory mechanisms.

[10]  Ru-Fang Yeh,et al.  TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.

[11]  Lin Fang,et al.  miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. , 2014, Oncology reports.

[12]  Klaus-Peter Lesch,et al.  Epigenetically regulated microRNAs in Alzheimer's disease , 2014, Neurobiology of Aging.

[13]  R. García-Becerra,et al.  Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance , 2012, International journal of molecular sciences.

[14]  Jeffrey T. Chang,et al.  Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties , 2013, Scientific Reports.

[15]  Yiwei Li,et al.  MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer , 2016, International journal of biological sciences.

[16]  Jeffrey M. Rosen,et al.  Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[17]  C. Perou,et al.  Defining breast cancer intrinsic subtypes by quantitative receptor expression. , 2015, The oncologist.

[18]  Guoping Fan,et al.  Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain , 2013, Nature Neuroscience.

[19]  R. Malekzadeh,et al.  Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker , 2009, BMC Cancer.

[20]  J. Bartlett,et al.  EMT in Breast Carcinoma—A Review , 2016, Journal of clinical medicine.

[21]  G. Ast,et al.  The alternative role of DNA methylation in splicing regulation. , 2015, Trends in genetics : TIG.

[22]  M. He,et al.  MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer , 2012, Carcinogenesis.

[23]  A. Masotti,et al.  A Bioinformatics Approach to the Identification of Variants Associated with Type 1 and Type 2 Diabetes Mellitus that Reside in Functionally Validated miRNAs Binding Sites , 2016, Biochemical Genetics.

[24]  M. Sang,et al.  Biomarkers for EMT and MET in breast cancer: An update. , 2016, Oncology letters.

[25]  김남희,et al.  A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition , 2011 .

[26]  J. Yun,et al.  miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. , 2014, Carcinogenesis.

[27]  N. Bhowmick,et al.  Role of EMT in Metastasis and Therapy Resistance , 2016, Journal of clinical medicine.

[28]  Aamir Ahmad,et al.  The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis , 2012, International journal of molecular sciences.

[29]  N. Cho,et al.  Alu and LINE-1 Hypomethylation Is Associated with HER2 Enriched Subtype of Breast Cancer , 2014, PloS one.

[30]  Y Pawitan,et al.  Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer , 2013, Oncogene.

[31]  Jingjing Liu,et al.  MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4 , 2012, PloS one.

[32]  C. Schumacher,et al.  NGS library preparation for balanced, comprehensive methylome coverage from low-input quantities , 2015, Nature Methods.

[33]  L. Fabris,et al.  Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? , 2015, Journal of clinical medicine.

[34]  C. Gigek,et al.  Methyl‐CpG‐Binding Protein (MBD) Family: Epigenomic Read‐Outs Functions and Roles in Tumorigenesis and Psychiatric Diseases , 2016, Journal of cellular biochemistry.

[35]  H. Ford,et al.  TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation. , 2015, Cancer research.

[36]  DaraeiAbdolreza,et al.  miRNA-Related Polymorphisms in miR-423 (rs6505162) and PEX6 (rs1129186) and Risk of Esophageal Squamous Cell Carcinoma in an Iranian Cohort. , 2017 .

[37]  D. Brutlag,et al.  A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[39]  Gregory J Goodall,et al.  Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state , 2013, Journal of Cell Science.

[40]  R. Bast,et al.  Phase 1b‐2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum‐resistant or platinum‐refractory epithelial ovarian cancer , 2011, Cancer.

[41]  A. Zaravinos The Regulatory Role of MicroRNAs in EMT and Cancer , 2015, Journal of oncology.

[42]  A. Choi,et al.  Identification and Functional Analysis of Epigenetically Silenced MicroRNAs in Colorectal Cancer Cells , 2011, PloS one.

[43]  H. Trompeter,et al.  Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells , 2010, BMC Research Notes.

[44]  Michael Q. Zhang,et al.  Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4 , 2014, Gut.

[45]  P. Vineis,et al.  Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort. , 2015, Carcinogenesis.

[46]  Kenneth P. Nephew,et al.  Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer , 2015, Oncotarget.

[47]  J. Makki,et al.  Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance , 2015, Clinical medicine insights. Pathology.

[48]  H. Höfler,et al.  Intratumoral heterogeneity of microRNA expression in breast cancer. , 2012, The Journal of molecular diagnostics : JMD.

[49]  S. Leng,et al.  EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. , 2011, Cancer research.

[50]  A. Brenner,et al.  Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors , 2017, Investigational New Drugs.

[51]  X. Li,et al.  MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance. , 2016, European Review for Medical and Pharmacological Sciences.

[52]  Martha R. Stampfer,et al.  Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells , 2010, PloS one.

[53]  T. Rohan,et al.  Hsa‐miR‐375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity , 2012, The Journal of pathology.

[54]  A. Masotti,et al.  MiRNA-Related Polymorphisms in miR-146a and TCF21 Are Associated with Increased Susceptibility to Coronary Artery Disease in an Iranian Population. , 2016, Genetic testing and molecular biomarkers.

[55]  J. Byrd,et al.  Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. , 2012, Cancer research.

[56]  Domenico Coppola,et al.  MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA , 2008, Molecular and Cellular Biology.

[57]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[58]  Zachary D. Smith,et al.  DNA methylation: roles in mammalian development , 2013, Nature Reviews Genetics.

[59]  Charles Y. Lin,et al.  Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer , 2016, Genome Biology.

[60]  Martha R. Stampfer,et al.  miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer , 2013, PloS one.

[61]  H. Taylor,et al.  H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase , 2015, Nature Communications.

[62]  N. Kushlinskii,et al.  Novel miRNA genes hypermethylated in breast cancer , 2016, Molecular Biology.

[63]  R. Ben Gacem,et al.  Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease , 2014, Tumor Biology.

[64]  Gregory Doyle,et al.  Pan-Canadian study of mammography screening and mortality from breast cancer. , 2014, Journal of the National Cancer Institute.

[65]  Fei Gao,et al.  Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer , 2016, Scientific Reports.

[66]  V. Band,et al.  Histological, molecular and functional subtypes of breast cancers , 2010, Cancer biology & therapy.

[67]  A. Hanby,et al.  In situ and invasive lobular neoplasia of the breast , 2007, Histopathology.

[68]  Y. Sang,et al.  Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis. , 2016, Oncology Report.

[69]  Yanli Tian,et al.  Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2 , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[70]  Nada Ahmed,et al.  Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies , 2015, Breast cancer : basic and clinical research.

[71]  Chuan He,et al.  HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis , 2013, Proceedings of the National Academy of Sciences.

[72]  G. Christofori,et al.  The relevance of EMT in breast cancer metastasis: Correlation or causality? , 2015, FEBS letters.

[73]  James D Doecke,et al.  Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types. , 2016, Cancer genetics.

[74]  M. Alivand,et al.  Probable Chemical Hypoxia Effects on Progress of CNV Through Induction of Promoter CpG Demethylation and Overexpression of IL17RC in Human RPE Cells , 2016, Current eye research.

[75]  Lianhong Li,et al.  MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[76]  Bo Xu,et al.  IsomiR Bank: a research resource for tracking IsomiRs , 2016, Bioinform..

[77]  R. Dai,et al.  The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation , 2016, PloS one.

[78]  H. Lodish,et al.  Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  F. Roviello,et al.  Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer , 2011, British Journal of Cancer.

[80]  M. Pornour,et al.  New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line. , 2015, Recent patents on anti-cancer drug discovery.

[81]  W. Park,et al.  miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines , 2013, PloS one.

[82]  Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[83]  Qin Xu,et al.  Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. , 2013, Carcinogenesis.

[84]  Wen-Ching Chan,et al.  Aberrant hypermethylation of miR-9 genes in gastric cancer , 2011, Epigenetics.

[85]  A. Masotti,et al.  Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes. , 2015, Genomics.

[86]  S. Qin,et al.  Let-7: a regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells. , 2013, Oncology reports.

[87]  J. Rich Cancer stem cells: master gatekeepers and regulators of cancer growth and metastasis Introduction , 2016, Medicine.

[88]  H. Salehiniya,et al.  Incidence and Mortality and Epidemiology of Breast Cancer in the World. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[89]  R. Maestro,et al.  Epigenetic silencing of miR‐200c in breast cancer is associated with aggressiveness and is modulated by ZEB1 , 2017, Genes, chromosomes & cancer.

[90]  Rodney J Scott,et al.  Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value , 2015, Nature Communications.

[91]  Christopher A. Maher,et al.  A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition , 2011, The Journal of cell biology.

[92]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.

[93]  C. Plass,et al.  Genome-wide epigenetic regulation of miRNAs in cancer. , 2013, Cancer research.

[94]  Hao Wu,et al.  Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions , 2014, Cell.

[95]  S. Kwak,et al.  miR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin. , 2016, Journal of molecular cell biology.

[96]  P. Wongtrakoongate Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries. , 2015, World journal of stem cells.

[97]  F. Lyko,et al.  Methylation of Human MicroRNA Genes in Normal and Neoplastic Cells , 2007, Cell cycle.

[98]  A. Menssen,et al.  miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions , 2011, Cell cycle.

[99]  Tanja Fehm,et al.  Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. , 2012, The New England journal of medicine.

[100]  I. Voutsadakis Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation , 2016, Journal of clinical medicine.

[101]  M. Esteller,et al.  DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer , 2011, Oncogene.

[102]  Michael J. Ziller,et al.  Saturation analysis for whole-genome bisulfite sequencing data , 2016, Nature Biotechnology.

[103]  Hsin-Yang Li,et al.  Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis , 2015, International journal of molecular sciences.

[104]  B. Verdoodt,et al.  Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas , 2011, Virchows Archiv.

[105]  Guangshun Wang,et al.  The role of microRNAs in human breast cancer progression , 2014, Tumor Biology.

[106]  C. Croce,et al.  Role of microRNAs in maintaining cancer stem cells. , 2015, Advanced drug delivery reviews.

[107]  B. White,et al.  ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer , 2012, Trends in Endocrinology & Metabolism.

[108]  S. Kwak,et al.  miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. , 2016, Biochimica et biophysica acta.

[109]  Yue Yu,et al.  Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer , 2015, Oncotarget.

[110]  D. Takai,et al.  Genome structure‐based screening identified epigenetically silenced microRNA associated with invasiveness in non‐small‐cell lung cancer , 2012, International journal of cancer.

[111]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[112]  J. Forbes,et al.  DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients , 2016, Scientific Reports.

[113]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[114]  Hiromu Suzuki,et al.  DNA methylation and microRNA dysregulation in cancer , 2012, Molecular oncology.

[115]  Di Wu,et al.  MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer , 2015, Oncotarget.

[116]  Yun Xiao,et al.  miR-429 inhibits migration and invasion of breast cancer cells in vitro , 2014, International journal of oncology.

[117]  S. Jang,et al.  Cap-dependent translation is mediated by ‘RNA looping’ rather than ‘ribosome scanning’ , 2015, RNA biology.

[118]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[119]  M. Ellis,et al.  The Cancer Genome Atlas: clinical applications for breast cancer. , 2013, Oncology.

[120]  Lei Wang,et al.  Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R , 2014, BMC Cancer.

[121]  A. Jeltsch,et al.  Mechanism and biological role of Dnmt2 in Nucleic Acid Methylation , 2016, RNA biology.

[122]  T. Ye,et al.  Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine , 2011, Chemotherapy research and practice.

[123]  U. Grossniklaus,et al.  Differentially Methylated Region-Representational Difference Analysis (DMR-RDA): A Powerful Method to Identify DMRs in Uncharacterized Genomes. , 2017, Methods in molecular biology.

[124]  Qin Xu,et al.  miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer , 2014, Molecular Cancer.

[125]  Yul Ri Chung,et al.  MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer , 2014, Breast Cancer Research and Treatment.

[126]  T. Ørntoft,et al.  Non‐CpG island promoter hypomethylation and miR‐149 regulate the expression of SRPX2 in colorectal cancer , 2013, International journal of cancer.

[127]  Massimo Negrini,et al.  In hepatocellular carcinoma miR‐519d is up‐regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 , 2012, The Journal of pathology.

[128]  X Wang,et al.  MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin , 2014, Oncogene.

[129]  Jian Jin,et al.  MiR‐489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway , 2014, FEBS letters.

[130]  Yu-rong Shi,et al.  MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells , 2012, Journal of Experimental & Clinical Cancer Research.

[131]  Rastgar Jazii Two Steps Methylation Specific PCR for Assessment of APC Promoter Methylation in Gastric Adenocarcinoma , 2011 .

[132]  Duan Ma,et al.  miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10 , 2012, BMC Cancer.

[133]  F. Ferrari,et al.  A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.

[134]  A. Masotti,et al.  In silico dissection of miRNA targetome polymorphisms and their role in regulating miRNA-mediated gene expression in esophageal cancer , 2016, Cell Biochemistry and Biophysics.

[135]  Jining Lu,et al.  Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer , 2011, Breast Cancer Research.

[136]  Jia Yu,et al.  DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer , 2014, Gastric Cancer.

[137]  M. Somi,et al.  miRNA-Related Polymorphisms in miR-423 (rs6505162) and PEX6 (rs1129186) and Risk of Esophageal Squamous Cell Carcinoma in an Iranian Cohort. , 2017, Genetic testing and molecular biomarkers.

[138]  S. Clark,et al.  Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer , 2012, Oncogene.

[139]  A. Dmitriev,et al.  DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. , 2017, Gene.

[140]  Sendurai A Mani,et al.  Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression , 2011, Breast Cancer Research.

[141]  M. Alivand,et al.  Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells , 2017, Journal of cellular biochemistry.

[142]  Kun Wang,et al.  Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1 , 2014, Oncogene.

[143]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[144]  Peter A. Jones,et al.  Targeting DNA methylation for epigenetic therapy. , 2010, Trends in pharmacological sciences.